Karl B Lemstrom
Overview
Explore the profile of Karl B Lemstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Broch K, Lemstrom K, Gustafsson F, Eiskjaer H, Karason K, Gjesdal G, et al.
JACC Heart Fail
. 2024 Jun;
12(10):1677-1688.
PMID: 38934968
Background: Cardiac allograft vasculopathy is characterized by increased coronary intimal thickness and is a leading cause of death in heart transplant (HTx) recipients despite the routine use of statins. The...
2.
Holmstrom E, Syrjala S, Dhaygude K, Tuuminen R, Krebs R, Lommi J, et al.
J Heart Lung Transplant
. 2024 Jun;
43(10):1677-1690.
PMID: 38897424
Background: Vascular endothelial growth factor (VEGF)-A is an angiogenic and proinflammatory cytokine with profound effects on microvascular permeability and vasodilation. Several processes may induce VEGF-A expression in brain-dead organ donors....
3.
Holmstrom E, Syrjala S, Dhaygude K, Tuuminen R, Krebs R, Nykanen A, et al.
J Heart Lung Transplant
. 2023 Feb;
42(6):807-818.
PMID: 36754701
Introduction: Heart transplant results have constantly improved but primary left ventricle graft dysfunction (LV-PGD) remains a devastating complication early after transplantation. Donor and recipient systemic inflammatory response may be involved...
4.
Friman T, Jaamaa-Holmberg S, Aberg F, Helantera I, Halme M, Pentikainen M, et al.
Int J Cancer
. 2022 Jan;
150(11):1779-1791.
PMID: 35041762
Cancer is a significant cause of morbidity and mortality after solid organ transplantation (SOT) and related to lifelong immunosuppression. This retrospective registry study assessed for the first time in Finland...
5.
Hurskainen M, Ainasoja O, Lemstrom K
J Cardiovasc Dev Dis
. 2021 Dec;
8(12).
PMID: 34940535
The median survival of patients with heart transplants is relatively limited, implying one of the most relevant questions in the field-how to expand the lifespan of a heart allograft? Despite...
6.
Lukac J, Dhaygude K, Saraswat M, Joenvaara S, Syrjala S, Holmstrom E, et al.
J Heart Lung Transplant
. 2021 Dec;
41(3):311-324.
PMID: 34933799
Background: The pathophysiological changes related to brain death may affect the quality of the transplanted organs and expose the recipients to risks. We probed systemic changes reflected in donor plasma...
7.
Krebs R, Tikkanen J, Raissadati A, Hollmen M, Dhaygude K, Lemstrom K
Am J Pathol
. 2021 Nov;
192(2):254-269.
PMID: 34774518
Obliterative bronchiolitis (OB) after lung transplantation is a nonreversible, life-threatening complication. Herein, the role of vascular endothelial growth factor receptor (Vegfr)-1 and -2 was investigated in the development of obliterative...
8.
Jaamaa-Holmberg S, Salmela B, Suojaranta R, Jokinen J, Lemstrom K, Lommi J
Eur J Cardiothorac Surg
. 2020 Aug;
58(3):664.
PMID: 32754735
No abstract available.
9.
Broch K, Gude E, Karason K, Dellgren G, Radegran G, Gjesdal G, et al.
Clin Transplant
. 2020 May;
34(9):e13984.
PMID: 32445429
Background: Cardiac allograft vasculopathy (CAV) is characterized by diffuse thickening of the arterial intima. Statins reduce the incidence of CAV, but despite the use of statins, CAV remains one of...
10.
Jaamaa-Holmberg S, Salmela B, Suojaranta R, Lemstrom K, Lommi J
Eur Heart J Acute Cardiovasc Care
. 2020 Feb;
9(4):333-341.
PMID: 32004079
Background: The use of venoarterial extracorporeal membrane oxygenation in cardiogenic shock keeps increasing, but its cost-utility is unknown. Methods: We studied retrospectively the cost-utility of venoarterial extracorporeal membrane oxygenation in...